These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3140701)

  • 1. Lymphokine-activated killer cells. Induction and function.
    Grimm EA; Owen-Schaub LB; Loudon WG; Yagita M
    Ann N Y Acad Sci; 1988; 532():380-6. PubMed ID: 3140701
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity.
    Hiserodt JC; Chambers WH
    Ann N Y Acad Sci; 1988; 532():395-404. PubMed ID: 3052213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
    Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV
    Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antitumor efficacy of lymphokine-activated killer (LAK) cells and gamma interferon production induced in vitro from peripheral blood lymphocytes of patients with malignant gliomas].
    Shimizu K; Miyao Y; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H; Nanjo M; Ishida N
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):760-6. PubMed ID: 3093611
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
    Grimm EA; Robb RJ; Roth JA; Neckers LM; Lachman LB; Wilson DJ; Rosenberg SA
    J Exp Med; 1983 Oct; 158(4):1356-61. PubMed ID: 6413638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
    J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.
    Hiserodt JC; Chambers WH; Herberman RB
    Ann Inst Pasteur Immunol; 1988; 139(4):466-78. PubMed ID: 2458744
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cancer with lymphokine-activated killer cells and interleukin-2.
    N Engl J Med; 1987 Oct; 317(15):961-3. PubMed ID: 3498120
    [No Abstract]   [Full Text] [Related]  

  • 11. Current understanding of the lymphokine-activated killer cell phenomenon.
    Yagita M; Grimm EA
    Prog Exp Tumor Res; 1988; 32():213-26. PubMed ID: 3131833
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.
    Andriole GL; Mulé JJ; Hansen CT; Linehan WM; Rosenberg SA
    J Immunol; 1985 Nov; 135(5):2911-3. PubMed ID: 3876368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokines and cancer.
    Cavallo G
    G Batteriol Virol Immunol; 1990; 83(1-12):156-63. PubMed ID: 2133324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity.
    Sheridan JF; Beck M; Aurelian L; Radowsky M
    J Infect Dis; 1985 Sep; 152(3):449-56. PubMed ID: 2411825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses.
    Brunswick M; Lake P
    J Exp Med; 1985 May; 161(5):953-71. PubMed ID: 2580939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.
    Mulé JJ; Smith CA; Rosenberg SA
    J Exp Med; 1987 Sep; 166(3):792-7. PubMed ID: 3498002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IL-2 system in B lymphocyte growth and differentiation].
    Minamoto S; Taniguchi T
    Tanpakushitsu Kakusan Koso; 1991 Mar; 36(4):673-8. PubMed ID: 2063016
    [No Abstract]   [Full Text] [Related]  

  • 19. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lymphokine activated killer (LAK) cells by immunosuppressive substance.
    Hamada F; Fuchimoto S; Orita K
    Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):81-95. PubMed ID: 2789420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.